ADC Therapeutics SA

US$1.58As of Sun 8 Nov 2026, 12:00 UTC
NYSE:ADCTHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (38.71%)
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.80
PE TTM —
TSR TTM (64.57%)
Mkt cap US$201.7M
ROIC (25.47%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.73
9.72%
(25.99%)
Hold 4|10|1|10|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.04
0.04
0.04
19.33%
25.28%
27.85%
10.93%
Revenue$M
8.177
8.209
8.241
8.348
(7.50%)
(6.86%)
(3.62%)
(0.58%)
Peers (US$201.7M)
Cap (US$)
PE
3.868B
18.46x
1.622B
97.95x
109.2M
—
202.2M
9.870x
Capital
TTM
5Y
10Y
Leveragex
1.555
0.540
0.451
EBIT/Intx
1.142
1.135
0.766
Own earn%
(23.43)
10.92
4.39
Sh yield%
28.26
36.25
34.57
Owners
Insiders/Inst%
9.38
24.68
Short interest%
0.57
SBC / revenue%
5.25
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
25–32
$1 testx
0.2
Incr. ROIC%
12